Filtros de búsqueda

Lista de obras de

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).

artículo científico publicado en 2012

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

artículo científico publicado en 2012

A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers

artículo científico publicado en 2012

Acceleration of interstitial lung disease induced by raltitrexed

artículo científico publicado en 2019

Advanced age influences the dynamic changes in circulating C-reactive protein following injury.

artículo científico publicado en 2013

Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway

artículo científico publicado en 2014

An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes

artículo científico publicado en 2013

An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials

scientific article published on 07 January 2014

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma

artículo científico publicado en 2012

An unexpected cause of pulmonary cannonball lesion

artículo científico publicado en 2014

Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reply

artículo científico publicado en 2020

Antibiotic therapy and outcome from immune-checkpoint inhibitors

scientific article published on 06 November 2019

Antibiotic-induced Dysbiosis as a Putative Actionable Driver of Cancer Immunity in Renal Cell Carcinoma

artículo científico publicado en 2020

Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy

artículo científico publicado en 2020

Artemisia: a divine dart against cancer?

artículo científico publicado en 2015

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

scientific article published on 12 September 2019

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

artículo científico publicado en 2020

Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma.

artículo científico publicado en 2018

Breaking Kuhn's paradigm in advanced hepatocellular carcinoma.

artículo científico publicado en 2017

CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinoma

scientific article published on 19 October 2012

Cancer-related inflammation: an emerging prognostic domain in metastatic castration-resistant prostate carcinoma

artículo científico publicado en 2014

Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients

artículo científico publicado en 2013

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

artículo científico publicado en 2020

Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma

article

Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma

scientific article published on 14 May 2018

Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study

scientific article published on 07 May 2019

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

artículo científico publicado en 2020

Clinical, ethical and financial implications of incidental imaging findings: experience from a phase I trial in healthy elderly volunteers.

artículo científico publicado en 2012

Combined PD-1/VEGFR blockade: a new era of treatment for hepatocellular cancer

artículo científico publicado en 2020

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study

scientific article published on 26 May 2016

Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

artículo científico publicado en 2020

Corrigendum to "A novel and validated prognostic index in hepatocellular carcinoma: The Inflammation Based Index (IBI)"

artículo científico publicado en 2016

Developing an objective marker to optimize patient selection and predict survival benefit in early-phase cancer trials.

artículo científico publicado en 2013

Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study

article

Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma-Authors' reply.

artículo científico publicado en 2018

Editorial: dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma--authors' reply

artículo científico publicado en 2015

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

artículo científico publicado en 2020

Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma.

artículo científico publicado en 2015

Evolution of HIV-Associated Lymphoma Over 3 Decades

artículo científico publicado en 2016

Evolving concepts in the management of drug resistant ovarian cancer: dose dense chemotherapy and the reversal of clinical platinum resistance

artículo científico

First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer

artículo científico publicado en 2014

Functional immune characterization of HIV-associated non-small-cell lung cancer

artículo científico publicado en 2018

Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease

artículo científico publicado en 2010

Gene of the month: Axl.

artículo científico publicado en 2016

Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship

artículo científico publicado en 2011

Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV co-infection.

artículo científico publicado en 2017

Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

artículo científico publicado en 2020

Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma

scientific article published on 04 June 2019

Imatinib induced pyoderma gangrenosum

scientific article published on 01 July 2013

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

scientific article published on 04 December 2019

Immune-based therapies for hepatocellular carcinoma

artículo científico publicado en 2020

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations

artículo científico publicado en 2012

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

scientific article published on 10 July 2020

Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study

artículo científico publicado en 2020

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy

artículo científico publicado en 2020

Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors

scientific article published on 12 December 2019

Inflammation as a validated prognostic determinant in carcinoma of unknown primary site

scientific article published on 29 October 2013

Inflammation-based prognostic indices in malignant pleural mesothelioma

artículo científico publicado en 2012

Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study

scientific article published on 18 December 2018

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

artículo científico publicado en 2020

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

scientific article published on 15 February 2019

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib

artículo científico publicado en 2017

Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease

artículo científico publicado en 2009

Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy

artículo científico publicado en 2016

Isogeneic comparison of primary and metastatic lung cancer identifies CX3CR1 as a molecular determinant of site-specific metastatic diffusion

artículo científico publicado en 2012

MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial

artículo científico publicado en 2020

Management of Hepatocellular Cancer in the time of SARS-CoV-2

artículo científico publicado en 2020

Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis

scientific article published on 13 May 2019

Melatonin: resetting the clock of cancer progression?

artículo científico publicado en 2015

Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using 18F-Fluorothymidine Positron Emission Tomography

artículo científico publicado en 2020

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

artículo científico publicado en 2021

Neoplastic infiltration of the sphenoid wing: a rare manifestation of metastatic colorectal cancer

scientific article published on 01 December 2011

On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study.

artículo científico publicado en 2017

PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity

scientific article published on 01 May 2019

PD-L1.

artículo científico publicado en 2017

Peptide receptor radionuclide therapy for metastatic paragangliomas.

artículo científico publicado en 2016

Perspectives on the neoadjuvant use of immunotherapy in hepatocellular carcinoma

artículo científico publicado en 2020

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

scientific article published on 01 August 2020

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

artículo científico publicado en 2019

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma

artículo científico publicado en 2018

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

artículo científico publicado en 2020

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

artículo científico

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

artículo científico publicado en 2014

Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis

artículo científico publicado en 2016

Programmed cell death ligands expression drives immune tolerogenesis across the diverse subtypes of neuroendocrine tumours

artículo científico publicado en 2020

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior

artículo científico publicado en 2017

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

artículo científico publicado en 2017

Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinoma

artículo científico publicado en 2020

Recent advances in HIV-associated Kaposi sarcoma

artículo científico publicado en 2019

Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy

artículo científico publicado en 2017

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.

artículo científico publicado en 2017

Reliability and Reproducibility of the Edmondson Grading of Hepatocellular Carcinoma Using Paired Core Biopsy and Surgical Resection Specimens ⬇️

artículo científico publicado el 1 de diciembre de 2010

Reply to: 'Validating the ALBI grade: Its current and future use in HCC prognostication'.

artículo científico publicado en 2016

Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate Cells

artículo científico publicado en 2018

Review article: delivering precision oncology in intermediate-stage liver cancer

artículo científico publicado en 2017

Shifting paradigms in the systemic management of hepatocellular carcinoma

scientific article published on 01 October 2020

Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis

artículo científico publicado en 2018

Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma.

artículo científico publicado en 2017

TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition.

artículo científico publicado en 2015

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.

artículo científico publicado en 2016

The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application.

artículo científico publicado en 2015

The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development.

artículo científico publicado en 2017

The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma.

artículo científico publicado en 2017

The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma ⬇️

artículo científico publicado el 29 de enero de 2013

The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma

scientific article published on 18 September 2019

Therapeutic hierarchy in hepatocellular carcinoma: A dispute of evidence versus practice

artículo científico publicado en 2019

Tissue biomarkers of prognostic significance in hepatocellular carcinoma

artículo científico publicado en 2014

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

artículo científico publicado en 2017

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

artículo científico publicado en 2021

Validation of the hepatoma arterial embolization prognostic score in European and Asian populations and proposed modification

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda